Alimera Sciences Inc financial data

Symbol
ALIM on Nasdaq
Industry
Pharmaceutical Preparations
Location
6310 Town Square, Suite 400, Alpharetta, GA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 263 % +90.4%
Quick Ratio 11.6 % +109%
Return On Equity -33.7 % -104%
Return On Assets -9.63 % +71%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.4M shares +518%
Common Stock, Shares, Outstanding 52.4M shares +495%
Entity Public Float 14.4M USD -53.2%
Common Stock, Value, Issued 524K USD +495%
Weighted Average Number of Shares Outstanding, Basic 54.4M shares +572%
Weighted Average Number of Shares Outstanding, Diluted 54.4M shares +673%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 99.7M USD +69.8%
Research and Development Expense 17.4M USD +5.53%
Selling and Marketing Expense 33.3M USD +35.9%
General and Administrative Expense 22.8M USD +49.7%
Operating Income (Loss) 199K USD +93.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.7M USD +38.7%
Income Tax Expense (Benefit) -43K USD -272%
Net Income (Loss) Attributable to Parent -14.7M USD +38.8%
Earnings Per Share, Basic 1.01 USD/shares +95.5%
Earnings Per Share, Diluted -0.25 USD/shares +89.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.8M USD -42.3%
Accounts Receivable, after Allowance for Credit Loss, Current 37.1M USD +64.1%
Inventory, Net 3.46M USD +227%
Assets, Current 55.4M USD +20.4%
Deferred Income Tax Assets, Net 101K USD -22.9%
Property, Plant and Equipment, Net 2.28M USD -7.59%
Operating Lease, Right-of-Use Asset 996K USD -22%
Assets 150M USD -2.93%
Accounts Payable, Current 10.2M USD +27%
Accrued Liabilities, Current 5.71M USD -4.9%
Liabilities, Current 19.8M USD +39.3%
Operating Lease, Liability, Noncurrent 1.69M USD -16.7%
Other Liabilities, Noncurrent 5.91M USD -0.59%
Liabilities 112M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.91M USD -4.38%
Retained Earnings (Accumulated Deficit) -428M USD -3.7%
Stockholders' Equity Attributable to Parent 38.8M USD -16.1%
Liabilities and Equity 150M USD -2.93%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -566K USD +74.4%
Net Cash Provided by (Used in) Financing Activities 2.97M USD -70.3%
Net Cash Provided by (Used in) Investing Activities -21K USD -133%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 52.4M shares +495%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.26M USD -71.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.9M USD -42%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.79M USD +32.2%
Operating Lease, Liability 2.23M USD -18%
Payments to Acquire Property, Plant, and Equipment 21K USD +133%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14.8M USD +37.4%
Lessee, Operating Lease, Liability, to be Paid 2.84M USD -20.1%
Property, Plant and Equipment, Gross 6.87M USD +4.27%
Operating Lease, Liability, Current 535K USD -21.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 488K USD +2.95%
Lessee, Operating Lease, Liability, to be Paid, Year One 474K USD -30.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 610K USD -27.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 503K USD +3.07%
Deferred Tax Assets, Operating Loss Carryforwards 44.3M USD +5.94%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 152K USD +35.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 518K USD +2.98%
Operating Lease, Payments 600K USD -10.2%
Additional Paid in Capital 465M USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 484K USD 0%
Depreciation, Depletion and Amortization 3.09M USD +353%
Deferred Tax Assets, Net of Valuation Allowance 104K USD -19.4%
Share-based Payment Arrangement, Expense 845K USD +274%
Interest Expense 13.7M USD +111%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%